Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefapixant in IC/BPS
NCT01569438Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Apr 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefapixant in interstitial cystitis (IC), bladder pain syndrome (BPS), sponsored by Merck & Co.. Started Apr 2012; status: terminated.
02
Drugs
gefapixant
03
Conditions
interstitial cystitis (IC)bladder pain syndrome (BPS)
Beyond the preview
Go deeper on NCT01569438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01569438.